PTPN22 and obesity due to melanocortin 4 receptor deficiency: However, our analysis did not indicate an association between these clinical manifestations in the TS group, which is similar to a previous study by Salinas-Santander et al. (2016), in which PTPN22 +1858G/A was not associated with differential susceptibility to overweight and the development of obesity in adolescents.